Structure

InChI Key SGUAFYQXFOLMHL-UHFFFAOYSA-N
Smiles CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1
InChI
InChI=1S/C19H24N2O3/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24)

Physicochemical Descriptors

Property Name Value
Molecular Formula C19H24N2O3
Molecular Weight 328.41
AlogP 2.14
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 4.0
Number of Rotational Bond 8.0
Polar Surface Area 95.58
Molecular species BASE
Aromatic Rings 2.0
Heavy Atoms 24.0
Assay Description Organism Bioactivity Reference
The compound was evaluated for the antagonistic activity against alpha-1 adrenergic receptor. Oryctolagus cuniculus 158.49 nM
The compound was evaluated for the antagonistic activity against beta-1 adrenergic receptor. Cavia porcellus 31.62 nM
The compound was evaluated for the antagonistic activity against beta-2 adrenergic receptor. Cavia porcellus 39.81 nM
DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) None 393.0 nM DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) None 225.0 nM
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin) Rattus norvegicus 57.0 nM DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin) Rattus norvegicus 23.0 nM
DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) Rattus norvegicus 583.0 nM DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) Rattus norvegicus 323.0 nM
DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) None 521.0 nM DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) None 256.0 nM
DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) None 10.0 nM DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) None 5.837 nM
DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) None 16.0 nM DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) None 11.0 nM
DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) None 763.0 nM
DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) None 800.0 nM
Inhibition of Capra hircus (goat) brain DPP-3 using Arg-Arg-4mbetaNA as substrate assessed as liberation of 4mbetaNA from substrate at 0.5 mM Capra hircus 70.0 %
Drug uptake in lysosomes of human Fa2N-4 cells assessed as inhibition of LysoTracker Red fluorescence at 500 uM after 30 mins relative to control Homo sapiens 25.0 %
Antiproliferative activity against human SK-MEL-5 cells assessed as cell growth inhibition at 100 uM incubated for 48 hrs by MTT assay relative to control Homo sapiens 36.2 %
Antiproliferative activity against human SK-MEL-28 cells assessed as cell growth inhibition at 100 uM measured after 48 hrs by MTT assay relative to control Homo sapiens 35.6 %
Antiproliferative activity against human A375 cells assessed as cell growth inhibition at 100 uM measured after 48 hrs by MTT assay relative to control Homo sapiens 38.1 %

Related Entries

Cross References

Resources Reference
ChEBI 167638
ChEMBL CHEMBL429
DrugBank DB00598
DrugCentral 1531
FDA SRS R5H8897N95
Human Metabolome Database HMDB0014736
Guide to Pharmacology 7207
KEGG C07063
PharmGKB PA164743150
PubChem 3869
SureChEMBL SCHEMBL4582